Yong-Jun Huh is Director at Artiva Biotherapeutics, Inc. (ARTV). They have made 1 open-market trade across 1 company since 2024, most recently 2024-07-22.
CIK 0001931083
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25.0M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARTV | 1,346,117 | $7.9M |
Shares reported on the most recent Form 4, priced at the 2024-07-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARTV | BUY | 2024-07-22 | 2024-07-22 | $12.00 | $25.0M | -10.8% | -22.5% | -19.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.